한국어
English
日本語
中文(简体)
Maviret Tablets
40mg
Tablet · Prescription medication · Combination
AbbVie Korea Co., Ltd.
Pibrentasvir is an antiviral ingredient that inhibits the replication of the hepatitis C virus.
MFDS ingredient code M267076
Pibrentasvir is an antiviral ingredient used in the treatment of hepatitis C that works by interfering with the replication of the virus. This ingredient belongs to the class of direct-acting antivirals and is aimed at suppressing the proliferation of the hepatitis virus.
Pibrentasvir blocks the function of specific proteins within the hepatitis C virus, preventing the virus from replicating. This helps reduce the viral load and prevents liver damage.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other antivirals, Pibrentasvir is effective against a wide range of hepatitis C virus genotypes. It also has a low likelihood of resistance development, contributing to higher treatment success rates.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.